| Ytd | 23.57% | |
| 1y | 24.48% |
| Open | 68.53 | Prev Close | 69.30 | Low | 67.64 | High | 69.51 | Mkt Cap | 220.18M |
| Vol | 12.53K | Avg Vol | 13.75K | EPS | 3.38 | P/E | 20.46 | Forward P/E | N/A |
| Beta | 0.36 | Short Ratio | 2.77 | Inst. Own | 73.66% | Dividend | 1.24 | Div Yield | 1.78 |
| Ex Div Date | 12-16 | Earning | 07-23 | 50-d Avg | 67.46 | 200-d Avg | 62.94 | 1yr Est | 0.00 |
UTMD News
SALT LAKE CITY, UT / ACCESS Newswire / May 5, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) annou
UTMD reports a year-over-year decline in Q1 earnings per share and sales, pressured by lost distribu
Utah Medical Products (NASDAQ:UTMD) reported quarterly earnings of $0.82 per share. This is a 10.87
SALT LAKE CITY, UT / ACCESS Newswire / April 23, 2026 / In the first calendar quarter (1Q) of 2026,
Utah Medical Products (NASDAQ: UTMD - Get Free Report) and INLIF (NASDAQ: INLF - Get Free Report) ar
UTMD's niche leadership, global footprint, and strong cash generation position it to benefit from ri
American Express leads featured reports as spending growth and digital investments drive gains, whil
Utah Medical Products, Inc. (NASDAQ: UTMD - Get Free Report) passed above its two hundred day moving
UTMD's Q4 earnings fall year over year due to weak OEM sales and lower international Filshie sales,
SALT LAKE CITY, UT / ACCESS Newswire / February 4, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD)
Utah Medical Products (NASDAQ:UTMD) reported quarterly earnings of $0.80 per share. This is a 6.42 p
SALT LAKE CITY, UT / ACCESS Newswire / January 29, 2026 / With some unexpected circumstances in 2025
Shares of Utah Medical Products, Inc. (NASDAQ: UTMD - Get Free Report) crossed above its 50-day movi
Terumo (OTCMKTS:TRUMY - Get Free Report) and Utah Medical Products (NASDAQ: UTMD - Get Free Report)
Utah Medical Products, Inc. (NASDAQ: UTMD - Get Free Report)'s share price passed below its 200-day
SALT LAKE CITY, UT / ACCESS Newswire / November 4, 2025 / Utah Medical Products, Inc. (Nasdaq:UTMD)
Utah Medical's Q3 earnings fell 20% year over year as order cancellations and tariffs pressured marg
SALT LAKE CITY, UT / ACCESS Newswire / October 23, 2025 / Utah Medical Products, Inc. (NASDAQ:UTMD)
Utah Medical's Q2 earnings decrease year over year on lower OEM sales and weak international demand,
SALT LAKE CITY, UT / ACCESS Newswire / July 29, 2025 / Utah Medical Products, Inc. (Nasdaq:UTMD) ann
Utah Medical Products Reports Q2 Decline
SALT LAKE CITY, UT / ACCESS Newswire / July 24, 2025 / Utah Medical Products, Inc. [Nasdaq:UTMD] rep